Trial Profile
Effects of sitagliptin addition versus sulfonylurea intensification on beta cell function in patients with type 2 diabetes inadequately controlled on sulfonylurea: a randomized, multicenter, open-label trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Mar 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Mar 2022 Status changed from recruiting to completed.
- 19 Feb 2011 New trial record